ReShape Lifesciences Inc. - FORM S-1/A - EX-23.1 - CONSENT OF KPMG LLP

file	filename
EX-10.13 - FORM OF CEO RETENTION AGREEMENT - ReShape Lifesciences Inc.	d223031dex1013.htm
EX-10.12 - FORM OF EXECUTIVE RETENTION AGREEMENT (NON-CEO) - ReShape Lifesciences Inc.	d223031dex1012.htm
EX-10.11 - BONUS PLAN - ReShape Lifesciences Inc.	d223031dex1011.htm
EX-10.9 - DISTRIBUTION AGREEMENT (BADER) - ReShape Lifesciences Inc.	d223031dex109.htm
EX-10.7 - OFFER LETTER BETWEEN THE REGISTRANT AND AMY VANDENBERG - ReShape Lifesciences Inc.	d223031dex107.htm
EX-10.6 - OFFER LETTER BETWEEN THE REGISTRANT AND MARK BRISTER - ReShape Lifesciences Inc.	d223031dex106.htm
EX-10.5 - OFFER LETTER BETWEEN THE REGISTRANT AND ANDREW RASDAL - ReShape Lifesciences Inc.	d223031dex105.htm
EX-10.4 - 2016 EMPLOYEE STOCK PURCHASE PLAN - ReShape Lifesciences Inc.	d223031dex104.htm
EX-10.3 - 2016 EQUITY INCENTIVE PLAN - ReShape Lifesciences Inc.	d223031dex103.htm
EX-10.1 - FORM OF INDEMNITY AGREEMENT - ReShape Lifesciences Inc.	d223031dex101.htm
EX-5.1 - OPINION OF FENWICK & WEST LLP - ReShape Lifesciences Inc.	d223031dex51.htm
EX-3.4 - FORM OF RESTATED BYLAWS - ReShape Lifesciences Inc.	d223031dex34.htm
EX-3.2 - FORM OF RESTATED CERTIFICATE OF INCORPORATION - ReShape Lifesciences Inc.	d223031dex32.htm
EX-3.1 - SEVENTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - ReShape Lifesciences Inc.	d223031dex31.htm
EX-1.1 - FORM OF UNDERWRITING AGREEMENT - ReShape Lifesciences Inc.	d223031dex11.htm
S-1/A - S-1/A - ReShape Lifesciences Inc.	d223031ds1a.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Obalon Therapeutics, Inc.:

We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.


		/s/ KPMG LLP

San Diego, California

September 23, 2016

ReShape Lifesciences Inc. - FORM S-1/A - EX-23.1 - CONSENT OF KPMG LLP - September 26, 2016